Twenty four cases of chronic hepatitis were treated with thymopeptide and compared with 24 controlled cases. The results revealed that in thymopeptide group the effective rate was 83.3%

whereas in the control group the effective rate was only 29.2%(P<0.01) . The number of the patients in both group whose SGPT were returned to normal was different (P<0.05) ; and SB decreased to normal level was 100% and 33% respectively (P<0.05) .The authors believed that the thymopeptide probably increased the activity of the TS cell so that it can improve the course of the disease. Obviously

these results showed that there was a significant difference between the study group anp controlled group. It seems that the thymopeptide may be a more effective drug